Shah Devang MD is categorized under Internal Medicine Doctors in Orange City, FL and active since 2011.
Shah Devang MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Devang Shah at the company’s single location by writing to 963 Town Center Drive # 100, Orange City, Florida FL 32763 or by phoning (386) 774-9880. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Shah Devang MD |
| Contact Person: | Devang Shah |
| Address: | 963 Town Center Drive # 100, Orange City, Florida 32763 |
| Phone Number: | (386) 774-9880 |
| Website Address: | myentdoctor.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Shah Devang MD was started in 2011 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Devang Shah for inquiries that concern Shah Devang MD by calling the company number (386) 774-9880, as your correspondence is most welcome. Additionally, the physical location of the single location of Shah Devang MD can be found at the coordinates 28.90782,-81.28776 as well as the street address 963 Town Center Drive # 100 in Orange City, Florida 32763.
For its online presence, you may visit Shah Devang MD’s website at myentdoctor.com and engage with its social media outlets through on Twitter and on Facebook.